A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)

Clinical trial NCT04834778 · COMPLETED

Trial details

NCT number: NCT04834778
Sponsor: HiberCell, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma Gastric Cancer Metastatic Breast Cancer Small-cell Lung Cancer Other Solid Tumors

Start date: 2021-06-08
Primary completion: 2023-12-07
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.